SCHEMBL18969016

SCHEMBL18969016

c1ccc(N(c2ccccc2)c2ccc(C3(c4ccccc4)c4cccc5oc6cccc3c6c45)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.36
MAPT P10636 2/20 0.36
ALDH1A1 P00352 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
LMNA P02545 2/20 0.33
OPRK1 P41145 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CRHBP P24387 1/20 0.32
ATM Q13315 1/20 0.32
CRHR2 Q13324 1/20 0.32
TLR9 Q9NR96 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18968985 0.95 KDM4E (0.33) KDM4EMAPTALDH1A1L3MBTL1CYP1A2
SCHEMBL18968956 0.94 KDM4E (0.33) KDM4EMAPTALDH1A1L3MBTL1CYP1A2
SCHEMBL18969018 0.94 KDM4E (0.33) KDM4EMAPTALDH1A1L3MBTL1CYP1A2
SCHEMBL18968979 0.92 KIF11 (0.30) KDM4EMAPTALDH1A1L3MBTL1CYP1A2
SCHEMBL18969020 0.92 KIF11 (0.30) KDM4EMAPTALDH1A1L3MBTL1CYP1A2
SCHEMBL18968994 0.91 KDM4E (0.31) KDM4EMAPTALDH1A1L3MBTL1CYP1A2
SCHEMBL18969022 0.88 AHR (0.37) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL18969010 0.87 KDM4E (0.30) KDM4EMAPTALDH1A1L3MBTL1CYP1A2
SCHEMBL18968996 0.87 KDM4E (0.30) KDM4EMAPTALDH1A1L3MBTL1CYP1A2
SCHEMBL18968997 0.87 KDM4E (0.30) KDM4EMAPTALDH1A1L3MBTL1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10361374-B2 Amine compound and organic light emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2019-07-23 US disclosed
US-20170170402-A1 AMINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-15 US disclosed
US-20170170402-A1 AMINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170170402-A1 AMINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME AOC2, MAOA, AOC3 KDM4E 1276/4885MAPT 121/4885ALDH1A1 78/4885
US-10361374-B2 Amine compound and organic light emitting device including the same AOC2, MAOA, AOC3 KDM4E 1276/4885MAPT 121/4885ALDH1A1 78/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.